✦ LIBER ✦

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease

✍ Scribed by B. Widner; F. Leblhuber; D. Fuchs

Publisher: Springer
Year: 2002
Tongue: English
Weight: 60 KB
Volume: 109
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s007020200014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neopterin production and tryptophan degr

Neopterin production and tryptophan degradation in humans infected byStreptococcus pyogenes

✍ Christian Murr; Dieter Gerlach; Bernhard Widner; Manfred P. Dierich; Dietmar Fuc 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 80 KB

Increased endogenous interferon-gamma an

Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection

✍ Dietmar Fuchs; Arnulf A. Möller; Gilbert Reibnegger; Ernst R. Werner; Gabriele W 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Tryptophan degradation and immune activa

Tryptophan degradation and immune activation in Alzheimer's disease

✍ B. Widner; F. Leblhuber; J. Walli; G. P. Tilz; U. Demel; D. Fuchs 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 106 KB

Increased blink rate in advanced Parkins

Increased blink rate in advanced Parkinson's disease: A form of ‘off’-period dystonia?

✍ T. E. Kimber; P. D. Thompson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 2 views

Blink rates were measured in 25 patients with fluctuating Parkinson's disease in the "off' and "on" periods. In 17 patients, the "off"-period blink rate was low and increased after administration of levodopa. In the remaining eight patients, the "off"-period blink rate was high and returned to norma

Swallowing and speech production in Park

Swallowing and speech production in Parkinson's disease

✍ Dr Jo Anne Robbins; Jerilyn A. Logemann; Howard S. Kirshner 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB 👁 2 views

Pharmacokinetics and effects of levodopa

Pharmacokinetics and effects of levodopa in advanced Parkinson's disease

✍ E. Bredberg; J. Tedroff; S.-M. Aquilonius; L. Paalzow 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 557 KB

Five patients with severe Parkinson's disease were characterized with respect to their pharmacokinetic and pharmacodynamic responses to levodopa given: orally, intravenously (three different infusion rates) and intraduodenally. The best therapeutic infusion rate in the intravenous study was used for